Webinar: Our experts discuss NICE's proportionate approach to technology appraisals and the implicat...
Read moreOur study aims to understand how the severity modifier has been implemented so far and its impact on...
Read moreLearn about the ground breaking consultation by NHS England and NICE on expanding the Antimicrobial ...
Read moreWe explore the issues faced by manufacturers and payers for oncology combination pricing and the pot...
Read moreUK, Canada and United States join forces to streamline process and increase transparency for confide...
Read moreOur client had concerns as to whether the clinical end-points in their phase III trial were relevant...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreNew process to assess clinical and cost-effectiveness of COVID-19 treatments to get these medicines ...
Read moreSpain will ask pharmaceutical companies to submit their economic evaluation studies to reviewed late...
Read moreNICE have recommended Enhertu for the treatment of HER2-positive breast cancer within a managed acce...
Read more